Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 201 TARS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 201 | n/a |
| Jun 29, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 3,837 | n/a |
| Jun 18, 2026 | RxSight, Inc. (RXST) | Grant/Award | 37,037 | n/a |
| Jun 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 10,572 | $655.1K |
| Jun 16, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,954 | n/a |
| Jun 5, 2026 | LENSAR, Inc. (LNSR) | Grant/Award | 17,421 | n/a |
| Mar 18, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 3,629 | $247.1K |
| Dec 17, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 5,046 | $407.7K |
| Sep 18, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Gift | 2,000 | n/a |
| Sep 10, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 27,116 | $1.55M |